Bares Capital Management Inc. increased its position in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 4.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 121,830 shares of the technology company’s stock after acquiring an additional 5,231 shares during the quarter. Veeva Systems comprises 2.3% of Bares Capital Management Inc.’s holdings, making the stock its 9th biggest position. Bares Capital Management Inc.’s holdings in Veeva Systems were worth $25,568,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Mowery & Schoenfeld Wealth Management LLC acquired a new stake in Veeva Systems in the third quarter worth about $26,000. True Wealth Design LLC raised its position in shares of Veeva Systems by 3,375.0% in the 3rd quarter. True Wealth Design LLC now owns 139 shares of the technology company’s stock valued at $29,000 after purchasing an additional 135 shares during the last quarter. Blue Trust Inc. boosted its stake in Veeva Systems by 3,460.0% in the 2nd quarter. Blue Trust Inc. now owns 178 shares of the technology company’s stock worth $33,000 after purchasing an additional 173 shares in the last quarter. DT Investment Partners LLC purchased a new stake in Veeva Systems during the 2nd quarter worth approximately $35,000. Finally, Fairscale Capital LLC acquired a new position in shares of Veeva Systems in the second quarter valued at about $46,000. Hedge funds and other institutional investors own 88.20% of the company’s stock.
Veeva Systems Trading Down 1.8 %
Shares of NYSE VEEV opened at $245.99 on Tuesday. Veeva Systems Inc. has a twelve month low of $169.98 and a twelve month high of $258.93. The firm has a 50-day moving average of $219.02 and a two-hundred day moving average of $203.12. The company has a market capitalization of $39.83 billion, a price-to-earnings ratio of 60.74, a PEG ratio of 2.43 and a beta of 0.82.
Insider Activity at Veeva Systems
Wall Street Analysts Forecast Growth
Several equities analysts recently issued reports on the stock. Guggenheim boosted their target price on shares of Veeva Systems from $233.00 to $249.00 and gave the company a “buy” rating in a research note on Tuesday, October 1st. JPMorgan Chase & Co. increased their price target on Veeva Systems from $203.00 to $208.00 and gave the company a “neutral” rating in a report on Monday, September 9th. Royal Bank of Canada lifted their price target on shares of Veeva Systems from $275.00 to $285.00 and gave the company an “outperform” rating in a research report on Friday. Bank of America raised their price target on Veeva Systems from $280.00 to $290.00 and gave the stock a “neutral” rating in a research report on Friday. Finally, BNP Paribas assumed coverage on Veeva Systems in a research note on Tuesday, October 8th. They issued an “outperform” rating and a $286.00 price objective on the stock. One research analyst has rated the stock with a sell rating, eight have given a hold rating and eighteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $255.35.
View Our Latest Report on Veeva Systems
Veeva Systems Company Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Further Reading
- Five stocks we like better than Veeva Systems
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Bargains Galore? 3 Stocks With Insider Buying in the Millions
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Is Amplitude an AI Sleeper Stock in the Making for 2025?
- Manufacturing Stocks Investing
- Pure Storage Rides the AI Boom Even Higher in 2025
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.